SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Natus Medical Inc – ‘8-K’ for 12/31/14

On:  Wednesday, 1/28/15, at 7:00am ET   ·   For:  12/31/14   ·   Accession #:  1171843-15-403   ·   File #:  0-33001

Previous ‘8-K’:  ‘8-K’ on / for 1/12/15   ·   Next:  ‘8-K’ on / for 4/22/15   ·   Latest:  ‘8-K’ on / for 7/21/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/28/15  Natus Medical Inc                 8-K:2,9    12/31/14    2:70K                                    Globenewswire Inc./FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Form 8-K Filing Document                            HTML     11K 
 2: EX-99       Press Release                                       HTML     31K 


8-K   —   Form 8-K Filing Document


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 8-K Filing  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 31, 2014 


Natus Medical Incorporated
(Exact name of registrant as specified in its charter)

Delaware 000-33001 77-0154833
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer Identification No.)

6701 Koll Center Parkway Suite 120
Pleasanton, CA 94566
94070
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:   925-223-6700

________________________________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    [   ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    [   ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    [   ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    [   ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02. Results of Operations and Financial Condition.

On January 28, 2015, Natus Medical Incorporated (the "Company") is issuing a press release and holding a conference call regarding its financial results for the fourth quarter ended December 31, 2014 and other financial information. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press release dated January 28, 2015 describing the Company's results for its fourth quarter ended December 31, 2014 and other financial information.


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Natus Medical Incorporated
(Registrant)


January 28, 2015
(Date)
  /s/   JONATHAN A. KENNEDY
Jonathan A. Kennedy
Senior Vice President Finance and Chief Financial Officer


Exhibit Index

Exhibit No. Description
99.1 Press release dated January 28, 2015 describing the Company's results for its fourth quarter ended December 31, 2014 and other financial information.




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:1/28/15None on these Dates
For Period End:12/31/14
 List all Filings 
Top
Filing Submission 0001171843-15-000403   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 8:20:44.1am ET